A Clinical Study to Assess Safety, Efficacy and In-use Tolerability of Different Dosages of Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III).

Conditions

• Androgenic Alopecia

Interventions

• OTHER: SesZen-Bio Low Dose 1 (350 mg extract)
• OTHER: SesZen-Bio Low Dose 1 (150 mg liposomal)
• OTHER: SesZen-Bio High Dose 1 (500 mg extract)
• OTHER: Placebo

Sponsor

NovoBliss Research Pvt Ltd

Collaborators

• [object Object]